glp-1 celiac Wegovy and Coeliac Disease: Safety, Considerations and Guidance GLP-1 and GLP-2 Orchestrate Intestine

Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, Lairez O, Drachman B, Garcia-Pavia P, Grogan M, et al

While branded GLP-1 medications often have specific criteriasuch as a BMI of 30 or higher, or 27 with weight-related health conditionscompounded medications allow greater flexibility

Health and safety risks Using unregulated or compounded peptides carries potential risks, including contamination, dosing inaccuracies, and unknown long-term effects

ArticlePubMedPMC 39

Many of our patients report lower blood pressure, improved blood sugar levels, and a renewed zest for life

If a dose is not tolerated during the escalation period, patients should consider delaying the next dose increase by four weeks